S. Kayal, J. Kikuchi, N. Shinagawa et al.
Tetrahedron xxx (xxxx) xxx
128.9, 127.0, 118.6, 77.3, 67.8, 32.0, 30.5, 25.4, 25.2, 21.3; IR (ATR):
2957, 2926, 2856, 2372, 1462, 1377, 925 cmꢀ1; HRMS(FDþ) m/z: [M]
Calcd for C15H18O 214.1358, Found: 214.1356.; HPLC analysis:
CHIRALCEL OD-3 (Hexane:iPrOH ¼ 99.9/0.1, 1.0 mL/min, 40 ꢁC,
220 nm) 6.2 min (minor), 7.1 min (major). Configuration Assign-
ment: The absolute configuration was assigned as (R) by analogy.
125.9, 125.3, 119.2, 68.0, 32.1, 30.6, 25.4, 25.2; IR (ATR): 3057, 3019,
2959, 2868, 1633, 1506, 1451, 1434, 1399, 1351, 1271, 1218, 1166,
1130, 1020, 984, 956 cmꢀ1; HRMS(FDþ) m/z: [M] Calcd for C18H18
O
250.1358, Found: 250.1356.; HPLC analysis: CHIRALPAK IA-3
(Hexane:iPrOH ¼ 99.3/0.7, 1.0 mL/min, 40 ꢁC, 220 nm) 5.5 min
(major), 5.9 min (minor). Configuration Assignment: The absolute
configuration was assigned as (R) by analogy.
4.2.4. (R)-2-(4-chlorophenyl)-2-vinyl-1-oxaspiro[2.4]heptane (3d)
82% yield (9.6 mg); colorless oil; [
a
]
22 þ18.5 (c 0.63, CHCl3, 85%
4.2.8. (R)-2-Phenyl-2-vinyl-1-oxaspiro[2.5]octane (3h)
D
ee); Rf ¼ 0.72 (Hexane/EtOAc ¼ 4/1); 1H NMR (600 MHz, CDCl3):
84% yield (9.0 mg); colorless oil; [
a
]
23 þ22.7 (c 0.96, CHCl3, 91%
D
d
7.33 (dt, J ¼ 9.0 Hz, 2.4 Hz, 2H), 7.28e7.25 (m, 2H), 6.02 (dd,
ee); Rf ¼ 0.70 (Hexane/EtOAc ¼ 4/1); 1H NMR (600 MHz, CDCl3):
J ¼ 17.4 Hz, 10.8 Hz, 1H), 5.31 (dd, J ¼ 10.2 Hz, 1.2 Hz, 1H), 5.17 (dd,
J ¼ 17.4 Hz, 1.8 Hz, 1H), 2.06e2.00 (m, 1H), 1.88e1.80 (m, 1H),
1.78e1.69 (m, 2H), 1.68e1.60 (m, 1H), 1.56e1.50 (m, 1H), 1.44e1.38
d
7.35e7.32 (m, 4H), 7.28e7.25 (m,1H), 6.18 (dd, J ¼ 16.8 Hz,10.8 Hz,
1H), 5.28 (dd, J ¼ 17.4 Hz, 1.8 Hz, 1H), 5.23 (dd, J ¼ 16.8 Hz, 1.2 Hz,
1H), 1.79e1.69 (m, 3H), 1.56e1.48 (m, 2H), 1.48e1.36 (m, 2H),
1.31e1.25 (m, 2H), 1.21e1.16 (m, 1H); 13C NMR (151 MHz, CDCl3):
(m, 1H), 1.30e1.23 (m, 1H); 13C NMR (151 MHz, CDCl3):
d 137.1,
136.8, 133.1, 128.5, 128.4, 119.2, 77.5, 67.4, 31.5, 30.5, 25.4, 25.2; IR
(ATR): 2958, 2869, 1713, 1633, 1491, 1453, 1399, 1278, 1219, 1091,
1015, 991, 930 cmꢀ1; HRMS(FDþ) m/z: [M] Calcd for C14H15ClO
234.0811, Found: 234.0808.; HPLC analysis: CHIRALPAK IA-3
(Hexane:iPrOH ¼ 99.3/0.7, 1.0 mL/min, 40 ꢁC, 220 nm) 5.0 min
(minor), 5.4 min (major). Configuration Assignment: The absolute
configuration was assigned as (R) by analogy.
d 138.8, 136.2, 128.1, 127.2, 127.0, 118.4, 70.5, 70.0, 31.7, 30.2, 25.7,
25.3, 24.7; IR (ATR): 2930, 2857, 1492, 1448, 1400, 1218, 985,
925 cmꢀ1; HRMS(FDþ) m/z: [M] Calcd for C15H18O 214.1358, Found:
214.1355.; HPLC analysis: CHIRALCEL OD-3 (Hexane:iPrOH ¼ 99.3/
0.7, 1.0 mL/min, 40 ꢁC, 220 nm) 4.0 min (minor), 4.4 min (major).
Configuration Assignment: The absolute configuration was
assigned as (R) by analogy.
4.2.5. (R)-2-([1,10-biphenyl]-4-yl)-2-vinyl-1-oxaspiro[2.4]heptane
4.3. Gram scale experiment
(3e)
73% yield (10.1 mg); colorless oil; [
a]
23 þ41.7 (c 0.76, CHCl3, 95%
In an oven and vacuum-dried reaction tube, MS 5A (1.1 g),
catalyst (R)-5b (171 mg, 0.14 mmol, 5 mol%) and PhB(OH)2 (16.8 mg,
0.14 mol, 5 mol%) were taken with 14 mL of Et2O. The reaction
mixture was stirred at room temperature for 15 min and then
cooled to ꢀ40 ꢁC. To the reaction mixture was added a solution of
2a (1.0 g, 2.8 mmol) in Et2O (14 mL) at the same temperature. After
being stirred for 48 h at ꢀ40 ꢁC, the reaction mixture was quenched
ee); Rf ¼ 0.71 (Hexane/EtOAc ¼ 4/1); 1DH NMR (600 MHz, CDCl3):
d
7.62e7.56 (m, 4H), 7.44 (t, J ¼ 7.8 Hz, 2H), 7.40 (d, J ¼ 8.4 Hz, 2H),
7.34 (tt, J ¼ 7.8 Hz, 1.2 Hz, 1H), 6.10 (dd, J ¼ 17.4 Hz,10.8 Hz, 1H), 5.33
(dd, J ¼ 10.8,1.2 Hz,1H), 5.24 (dd, J ¼ 18.0,1.8 Hz,1H), 2.09e2.03 (m,
1H), 1.89e1.82 (m, 1H), 1.80e1.71 (m, 2H), 1.70e1.62 (m, 1H),
1.60e1.54 (m, 1H), 1.54e1.46 (m, 1H), 1.37e1.31 (m, 1H); 13C NMR
(151 MHz, CDCl3):
d
140.9, 140.1, 137.6, 137.1, 128.9, 127.5, 127.4,
with NEt3 (600 mL) and directly purified by flash column chroma-
127.2, 126.9, 118.9, 77.5, 67.8, 32.0, 30.6, 25.4, 25.3; IR (ATR): 2920,
2860, 2312, 1730, 1600, 1459, 1219, 1086 cmꢀ1; HRMS(FDþ) m/z:
[M] Calcd for C20H20O 276.1514, Found: 276.1512.; HPLC analysis:
CHIRALCEL OD-3 (Hexane:iPrOH ¼ 99.3/0.7, 1.0 mL/min, 40 ꢁC,
220 nm) 5.2 min (minor), 5.5 min (major). Configuration Assign-
ment: The absolute configuration was assigned as (R) by analogy.
tography (Hexane/EtOAc ¼ 10:1) to give 3a (376 mg, 68%). The
enantiomeric excess was determined by chiral stationary phase
HPLC analysis.
4.4. Derivatization of product 3a to all-carbon quaternary
cyclohexanone 4a
a-vinyl
4.2.6. (R)-2-(4-(trifluoromethyl)phenyl)-2-vinyl-1-oxaspiro[2.4]
To a solution of 3a (10.0 mg, 0.05 mmol) in hexane (1.0 mL) was
added 1.0 M solution of Et2AlCl in n-hexane (50 L, 1.0 equiv.)
heptane (3f)
m
25
63% yield (8.5 mg); colorless oil; [
a]
þ4.7 (c 0.68, CHCl3, 69%
at ꢀ78 ꢁC. After the reaction mixture was stirred for 3 h at the same
temperature, the resulting mixture was quenched with NaHCO3 aq.
The resulting solution was extracted with EtOAc. The combined
EtOAc extracts were washed with brine, dried over Na2SO4 and
concentrated after filtration. The residual crude was purified by
flash column chromatography (Hexane/EtOAc ¼ 19/1) to give the
4a. The enantiomeric excess was determined by chiral stationary
phase HPLC analysis.
D
ee); Rf ¼ 0.33 (Hexane/EtOAc ¼ 10/1); 1H NMR (600 MHz, CDCl3):
d
7.61 (d, J ¼ 8.4 Hz, 2H), 7.46 (d, J ¼ 7.8 Hz, 2H), 6.05 (dd, J ¼ 17.4 Hz,
10.8 Hz, 1H), 5.34 (dd, J ¼ 10.2 Hz, 0.6 Hz, 1H), 5.18 (dd, J ¼ 17.4 Hz,
1.2 Hz,1H), 2.08e2.02 (m,1H),1.89e1.81 (m,1H),1.80e1.70 (m, 2H),
1.69e1.61 (m, 1H), 1.59e1.51 (m, 1H), 1.40e1.35 (m, 1H), 1.29e1.23
(m, 1H); 13C NMR (151 MHz, CDCl3):
d 142.7, 136.4, 129.6 (q,
J ¼ 31.7 Hz), 127.5, 125.2 (q, J ¼ 4.2 Hz), 124.3 (q, J ¼ 271.8 Hz), 119.4,
77.6, 67.5, 31.9, 30.5, 25.3, 25.2; IR (ATR): 2957, 2924, 2854, 2372,
2320, 1465, 1325, 1261, 1023 cmꢀ1; HRMS(FDþ) m/z: [M] Calcd for
4.4.1. (R)-2-Phenyl-2-vinylcyclohexan-1-one (4a)
25
C
15H17F3O 268.1075, Found: 268.1074.; HPLC analysis: CHIRALCEL
95% yield (9.5 mg), colorless oil; [
a
]
‒74.8 (c 0.38, CHCl3, 94%
D
OD-3 (Hexane:iPrOH ¼ 99.9/0.1, 1.0 mL/min, 40 ꢁC, 220 nm) 4.8 min
(minor), 5.0 min (major). Configuration Assignment: The absolute
configuration was assigned as (R) by analogy.
ee); 1H NMR (600 MHz, CDCl3):
d
7.37 (t, J ¼ 7.9 Hz, 2H), 7.28e7.26
(m, 1H), 7.19e7.18 (m, 2H), 6.25 (dd, J ¼ 17.5, 10.7 Hz, 1H), 5.12 (d,
J ¼ 10.3 Hz,1H), 4.56 (d, J ¼ 17.9 Hz,1H), 2.65 (qd, J ¼ 7.0, 3.1 Hz,1H),
2.46e2.38 (m, 2H), 2.01e1.94 (m, 2H), 1.82e1.76 (m, 3H); 13C NMR
4.2.7. (R)-2-(naphthalen-2-yl)-2-vinyl-1-oxaspiro[2.4]heptane (3g)
(151 MHz, CDCl3): d 212.5,143.3,139.7,128.9,127.6,127.1,115.0, 61.2,
64% yield (8.0 mg); colorless oil; [
a
]
22 þ58.1 (c 0.90, CHCl3, 82%
40.2, 36.3, 28.2, 21.6; IR (ATR): 3391, 3086, 2866, 2370, 1601, 1513,
1495, 1449, 1377, 1311, 1246, 1219, 1185, 1120, 1080, 1030, 967,
D
ee); Rf ¼ 0.71 (Hexane/EtOAc ¼ 4/1); 1H NMR (600 MHz, CDCl3):
d
7.86e7.11 (m, 4H), 7.50e7.43 (m, 3H), 6.14 (dd, J ¼ 17.4, 10.8 Hz,
920 cmꢀ1
;
HRMS (ESI) m/z: [MþNa]þ Calcd for C14H16NaO
1H), 5.34 (dd, J ¼ 10.8, 1.2 Hz, 1H), 5.21 (dd, J ¼ 16.8, 1.2 Hz, 1H),
2.14e2.05 (m, 1H), 1.90e1.78 (m, 2H), 1.78e1.64 (m, 2H), 1.60e1.51
(m, 1H), 1.49e1.42 (m, 1H), 1.33e1.25 (m, 1H); 13C NMR (151 MHz,
223.1093, Found: 223.1093.; HPLC analysis: Chiralpak OJ-H
(Hexane:iPrOH ¼ 99.5/0.5, 1.0 mL/min, 25 ꢁC, 220 nm) 11.3 min
(minor), 13.0 min (major). Configuration Assignment: The absolute
configuration was assigned as (R) by derivatization.
CDCl3): d 137.2, 136.2, 133.3, 132.8, 128.1, 127.83,127.79, 126.3, 126.0,
6